Terumo To Expand Cerebral Aneurysm Device Sales In The U.S., Other Markets
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Terumo plans to expand its product line of cerebral aneurysm and other brain treatment devices in the U.S. and overseas markets with hopes of reaching ¥10 billion ($992 million) in cerebral aneurism device sales by March 2011, Terumo said Sept. 3